Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Endostar timing with paclitaxel + cisplatin for advanced non-small cell lung cancer
ChiCTR-TRC-12002363Phase 4Completed
- Sponsor
- Affiliated Hospital of Southwest Medical University
- Start
- Apr 2012
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of endostar in non-small cell lung cancer (NSCLC) (3 arms), sponsored by Affiliated Hospital of Southwest Medical University. Primary endpoints: CT perfusion imaging parameters, Paclitaxel blood concentration and 1 more. Started Apr 2012; status: completed.
02
Drugs
endostar
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on ChiCTR-TRC-12002363.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-12002363.